10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine

C200H119N17O12S3 — CID 158108875

IUPAC10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine
SMILESc1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)c4cc(-c5nc6ccccc6o5)cc(N5c6ccccc6Oc6ccccc65)c4c3)nc3ccccc32)cc1.c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3o2)cc2c(N3c4ccccc4Oc4ccccc43)cc(-c3nc4ccccc4o3)cc12.c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3s2)cc2c(N3c4ccccc4Oc4ccccc43)cc(-c3nc4ccccc4o3)cc12.c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2ccc(N3c4ccccc4Sc4ccccc43)cc2-c2nc3ccccc3s2)c(-c2nc3ccccc3o2)c1
InChIInChI=1S/C54H33N5O3.C50H30N4O2S2.C48H28N4O4.C48H28N4O3S/c1-2-16-36(17-3-1)57-41-20-6-4-18-39(41)55-53(57)34-30-37-38(46(32-34)58-42-21-7-12-26-49(42)60-50-27-13-8-22-43(50)58)31-35(54-56-40-19-5-11-25-48(40)62-54)33-47(37)59-44-23-9-14-28-51(44)61-52-29-15-10-24-45(52)59;1-7-19-43-37(13-1)51-49(56-43)35-29-31(53-39-15-3-8-20-44(39)55-45-21-9-4-16-40(45)53)25-27-33(35)34-28-26-32(30-36(34)50-52-38-14-2-10-22-46(38)58-50)54-41-17-5-11-23-47(41)57-48-24-12-6-18-42(48)54;1-7-19-41-33(13-1)49-47(55-41)29-25-31-32(39(27-29)51-35-15-3-9-21-43(35)53-44-22-10-4-16-36(44)51)26-30(48-50-34-14-2-8-20-42(34)56-48)28-40(31)52-37-17-5-11-23-45(37)54-46-24-12-6-18-38(46)52;1-7-19-41-33(13-1)49-47(55-41)29-25-31-32(39(27-29)51-35-15-3-8-20-42(35)53-43-21-9-4-16-36(43)51)26-30(48-50-34-14-2-12-24-46(34)56-48)28-40(31)52-37-17-5-10-22-44(37)54-45-23-11-6-18-38(45)52/h1-33H;1-30H;2*1-28H
InChIKeyFQEFGLUSFZQWOI-UHFFFAOYSA-N
MW3048.46 g/mol
LogP57.44
Rot. Bonds18

About 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine

10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine (PubChem CID 158108875) has the molecular formula C200H119N17O12S3 and a molecular weight of 3048.46 g/mol. Its IUPAC name is 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine.

Molecular Properties

Compound Name10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine
PubChem CID158108875
Molecular FormulaC200H119N17O12S3
Molecular Weight3048.46 g/mol
Exact Mass3045.84
IUPAC Name10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine
SMILESc1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)c4cc(-c5nc6ccccc6o5)cc(N5c6ccccc6Oc6ccccc65)c4c3)nc3ccccc32)cc1.c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3o2)cc2c(N3c4ccccc4Oc4ccccc43)cc(-c3nc4ccccc4o3)cc12.c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3s2)cc2c(N3c4ccccc4Oc4ccccc43)cc(-c3nc4ccccc4o3)cc12.c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2ccc(N3c4ccccc4Sc4ccccc43)cc2-c2nc3ccccc3s2)c(-c2nc3ccccc3o2)c1
InChIInChI=1S/C54H33N5O3.C50H30N4O2S2.C48H28N4O4.C48H28N4O3S/c1-2-16-36(17-3-1)57-41-20-6-4-18-39(41)55-53(57)34-30-37-38(46(32-34)58-42-21-7-12-26-49(42)60-50-27-13-8-22-43(50)58)31-35(54-56-40-19-5-11-25-48(40)62-54)33-47(37)59-44-23-9-14-28-51(44)61-52-29-15-10-24-45(52)59;1-7-19-43-37(13-1)51-49(56-43)35-29-31(53-39-15-3-8-20-44(39)55-45-21-9-4-16-40(45)53)25-27-33(35)34-28-26-32(30-36(34)50-52-38-14-2-10-22-46(38)58-50)54-41-17-5-11-23-47(41)57-48-24-12-6-18-42(48)54;1-7-19-41-33(13-1)49-47(55-41)29-25-31-32(39(27-29)51-35-15-3-9-21-43(35)53-44-22-10-4-16-36(44)51)26-30(48-50-34-14-2-8-20-42(34)56-48)28-40(31)52-37-17-5-11-23-45(37)54-46-24-12-6-18-38(46)52;1-7-19-41-33(13-1)49-47(55-41)29-25-31-32(39(27-29)51-35-15-3-8-20-42(35)53-43-21-9-4-16-36(43)51)26-30(48-50-34-14-2-12-24-46(34)56-48)28-40(31)52-37-17-5-10-22-44(37)54-45-23-11-6-18-38(45)52/h1-33H;1-30H;2*1-28H
InChIKeyFQEFGLUSFZQWOI-UHFFFAOYSA-N
XLogP57.44
TPSA264.28 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds18
Heavy Atoms232
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003048.46
LogP ≤ 557.44
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Analyze 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine?
The IUPAC name of 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine (CID 158108875) is 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine.
What is the SMILES notation for 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine?
The canonical SMILES for 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine is c1ccc(-n2c(-c3cc(N4c5ccccc5Oc5ccccc54)c4cc(-c5nc6ccccc6o5)cc(N5c6ccccc6Oc6ccccc65)c4c3)nc3ccccc32)cc1.c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3o2)cc2c(N3c4ccccc4Oc4ccccc43)cc(-c3nc4ccccc4o3)cc12.c1ccc2c(c1)Oc1ccccc1N2c1cc(-c2nc3ccccc3s2)cc2c(N3c4ccccc4Oc4ccccc43)cc(-c3nc4ccccc4o3)cc12.c1ccc2c(c1)Oc1ccccc1N2c1ccc(-c2ccc(N3c4ccccc4Sc4ccccc43)cc2-c2nc3ccccc3s2)c(-c2nc3ccccc3o2)c1.
What is the InChIKey of 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine?
The InChIKey is FQEFGLUSFZQWOI-UHFFFAOYSA-N. The full InChI is InChI=1S/C54H33N5O3.C50H30N4O2S2.C48H28N4O4.C48H28N4O3S/c1-2-16-36(17-3-1)57-41-20-6-4-18-39(41)55-53(57)34-30-37-38(46(32-34)58-42-21-7-12-26-49(42)60-50-27-13-8-22-43(50)58)31-35(54-56-40-19-5-11-25-48(40)62-54)33-47(37)59-44-23-9-14-28-51(44)61-52-29-15-10-24-45(52)59;1-7-19-43-37(13-1)51-49(56-43)35-29-31(53-39-15-3-8-20-44(39)55-45-21-9-4-16-40(45)53)25-27-33(35)34-28-26-32(30-36(34)50-52-38-14-2-10-22-46(38)58-50)54-41-17-5-11-23-47(41)57-48-24-12-6-18-42(48)54;1-7-19-41-33(13-1)49-47(55-41)29-25-31-32(39(27-29)51-35-15-3-9-21-43(35)53-44-22-10-4-16-36(44)51)26-30(48-50-34-14-2-8-20-42(34)56-48)28-40(31)52-37-17-5-11-23-45(37)54-46-24-12-6-18-38(46)52;1-7-19-41-33(13-1)49-47(55-41)29-25-31-32(39(27-29)51-35-15-3-8-20-42(35)53-43-21-9-4-16-36(43)51)26-30(48-50-34-14-2-12-24-46(34)56-48)28-40(31)52-37-17-5-10-22-44(37)54-45-23-11-6-18-38(45)52/h1-33H;1-30H;2*1-28H.
What are the key properties of 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine?
10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine has a molecular weight of 3048.46 g/mol, XLogP of 57.44, 18 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[3-(1,3-benzothiazol-2-yl)-7-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine;10-[4-[2-(1,3-benzothiazol-2-yl)-4-phenothiazin-10-ylphenyl]-3-(1,3-benzoxazol-2-yl)phenyl]phenoxazine;10-[3-(1,3-benzoxazol-2-yl)-5-phenoxazin-10-yl-7-(1-phenylbenzimidazol-2-yl)naphthalen-1-yl]phenoxazine;10-[3,7-bis(1,3-benzoxazol-2-yl)-5-phenoxazin-10-ylnaphthalen-1-yl]phenoxazine is sourced from PubChem (CID 158108875), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).